End-of-day quote
Taipei Exchange
06:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
83
TWD
|
-2.24%
|
|
+3.49%
|
+12.31%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
347.8
|
459.7
|
1,268
|
1,220
|
904.7
|
3,027
|
Enterprise Value (EV)
1 |
318.7
|
418
|
1,137
|
952.6
|
429.3
|
2,410
|
P/E ratio
|
15.6
x
|
19.4
x
|
11.2
x
|
9.01
x
|
6.38
x
|
12.3
x
|
Yield
|
-
|
1.03%
|
2.5%
|
2.48%
|
11.2%
|
3.38%
|
Capitalization / Revenue
|
0.96
x
|
1.18
x
|
1.61
x
|
1.45
x
|
1.33
x
|
3.43
x
|
EV / Revenue
|
0.88
x
|
1.07
x
|
1.44
x
|
1.13
x
|
0.63
x
|
2.73
x
|
EV / EBITDA
|
5.24
x
|
5.86
x
|
5.95
x
|
3.84
x
|
1.95
x
|
6.57
x
|
EV / FCF
|
-7.52
x
|
19
x
|
12.1
x
|
6.58
x
|
2.65
x
|
16
x
|
FCF Yield
|
-13.3%
|
5.25%
|
8.23%
|
15.2%
|
37.8%
|
6.25%
|
Price to Book
|
1.16
x
|
1.4
x
|
2.82
x
|
2.24
x
|
1.36
x
|
3.73
x
|
Nbr of stocks (in thousands)
|
40,283
|
41,780
|
41,780
|
40,283
|
40,662
|
40,962
|
Reference price
2 |
8.635
|
11.00
|
30.35
|
30.30
|
22.25
|
73.90
|
Announcement Date
|
4/12/19
|
4/10/20
|
4/29/21
|
4/26/22
|
3/28/23
|
4/2/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
363.9
|
391.2
|
789.8
|
840.7
|
678
|
882
|
EBITDA
1 |
60.76
|
71.36
|
191
|
248.3
|
219.8
|
367.1
|
EBIT
1 |
22.08
|
27.17
|
143.3
|
192.5
|
153.8
|
304.2
|
Operating Margin
|
6.07%
|
6.95%
|
18.14%
|
22.89%
|
22.68%
|
34.5%
|
Earnings before Tax (EBT)
1 |
24.58
|
22.22
|
129.3
|
184.4
|
200.1
|
330.8
|
Net income
1 |
22.31
|
22.84
|
112.6
|
142.8
|
147.5
|
251.9
|
Net margin
|
6.13%
|
5.84%
|
14.25%
|
16.99%
|
21.75%
|
28.56%
|
EPS
2 |
0.5539
|
0.5670
|
2.709
|
3.364
|
3.490
|
6.000
|
Free Cash Flow
1 |
-42.39
|
21.94
|
93.59
|
144.8
|
162.2
|
150.6
|
FCF margin
|
-11.65%
|
5.61%
|
11.85%
|
17.23%
|
23.93%
|
17.07%
|
FCF Conversion (EBITDA)
|
-
|
30.75%
|
49%
|
58.32%
|
73.8%
|
41.01%
|
FCF Conversion (Net income)
|
-
|
96.07%
|
83.14%
|
101.42%
|
110.01%
|
59.76%
|
Dividend per Share
|
-
|
0.1138
|
0.7588
|
0.7517
|
2.482
|
2.500
|
Announcement Date
|
4/12/19
|
4/10/20
|
4/29/21
|
4/26/22
|
3/28/23
|
4/2/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
29.2
|
41.7
|
131
|
268
|
475
|
617
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-42.4
|
21.9
|
93.6
|
145
|
162
|
151
|
ROE (net income / shareholders' equity)
|
7.61%
|
7.42%
|
30.1%
|
29.2%
|
24.3%
|
34.1%
|
ROA (Net income/ Total Assets)
|
3.21%
|
3.56%
|
14.2%
|
14.3%
|
9.71%
|
16.1%
|
Assets
1 |
694
|
642.2
|
794.9
|
998.6
|
1,518
|
1,565
|
Book Value Per Share
2 |
7.450
|
7.840
|
10.70
|
13.50
|
16.40
|
19.80
|
Cash Flow per Share
2 |
1.740
|
2.170
|
3.530
|
7.290
|
12.60
|
15.60
|
Capex
1 |
53.3
|
67.9
|
54.2
|
102
|
80.4
|
53.4
|
Capex / Sales
|
14.65%
|
17.36%
|
6.86%
|
12.17%
|
11.85%
|
6.06%
|
Announcement Date
|
4/12/19
|
4/10/20
|
4/29/21
|
4/26/22
|
3/28/23
|
4/2/24
|
|
1st Jan change
|
Capi.
|
---|
| +12.31% | 106M | | +10.58% | 8.27B | | -2.97% | 4.7B | | -4.77% | 2.98B | | +5.75% | 2.15B | | -28.18% | 1.1B | | -2.65% | 865M | | -22.90% | 759M | | -55.35% | 708M | | -22.96% | 688M |
Scientific & Precision Equipment
|